BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11845294)

  • 1. Cystic fibrosis and CFTR.
    Greger R; Schreiber R; Mall M; Wissner A; Hopf A; Briel M; Bleich M; Warth R; Kunzelmann K
    Pflugers Arch; 2001; 443 Suppl 1():S3-7. PubMed ID: 11845294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome.
    Sheridan MB; Fong P; Groman JD; Conrad C; Flume P; Diaz R; Harris C; Knowles M; Cutting GR
    Hum Mol Genet; 2005 Nov; 14(22):3493-8. PubMed ID: 16207733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
    Li C; Naren AP
    Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
    Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of CFTR and ENaC in sweat glands.
    Reddy MM; Quinton PM
    Pflugers Arch; 2003 Jan; 445(4):499-503. PubMed ID: 12548396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis and related diseases of the pancreas.
    Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis.
    Mall M; Hirtz S; Gonska T; Kunzelmann K
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():165-9. PubMed ID: 15463952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENaC is inhibited by an increase in the intracellular Cl(-) concentration mediated through activation of Cl(-) channels.
    Kunzelmann K
    Pflugers Arch; 2003 Jan; 445(4):504-12. PubMed ID: 12548397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular studies of CFTR interacting proteins.
    Wang S; Li M
    Pflugers Arch; 2001; 443 Suppl 1():S62-4. PubMed ID: 11845305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFTR may play a role in regulated secretion by lymphocytes: a new hypothesis for the pathophysiology of cystic fibrosis.
    Bubien JK
    Pflugers Arch; 2001; 443 Suppl 1():S36-9. PubMed ID: 11845300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocyte biology and cystic fibrosis liver disease.
    Feranchak AP; Sokol RJ
    Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
    Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
    Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator.
    Kunzelmann K; Schreiber R; Nitschke R; Mall M
    Pflugers Arch; 2000 Jun; 440(2):193-201. PubMed ID: 10898518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions of HCO3- with cystic fibrosis transmembrane conductance regulator.
    Gray MA; O'Reilly C; Winpenny J; Argent B
    JOP; 2001 Jul; 2(4 Suppl):207-11. PubMed ID: 11875261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.